84
75
Growth Score 84 in past quarter
-3 pts
Heat Score 75 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
104209
Xcell Therapeutics focuses on commercial-scale serum-free chemically defined media for regenerative medicine.
- Uri Uiil Lee: Chief Executive Officer
About the Company
Xcell Therapeutics operates as a pharmaceutical company that engages in the development and production of drugs for cell therapy. The Company researches, develops and manufactures Xcell Therapeutics, clonally selected MSCs, automated mass cell culture, MSC-derived exosomes, and other related products. In addition, it develops media for cell
culture in various areas of the bioindustry, such as cell therapy, gene therapy, exosomes, organoids and bioreactors.